NCT05473364View on ClinicalTrials.gov

Acetazolamide in Persons With Type 1 Diabetes - Dose Finding

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 20, 2023

Primary Completion Date

February 23, 2024

Study Completion Date

July 31, 2024

Conditions
Type 1 Diabetes
Interventions
DRUG

Acetazolamide

Diuretic and carbonic anhydrase inhibitor medication

Trial Locations (1)

92037

UC San Diego Altman Clinical & Translational Research Institute, La Jolla

Sponsors
All Listed Sponsors
collaborator

Juvenile Diabetes Research Foundation

OTHER

lead

University of California, San Diego

OTHER

NCT05473364 - Acetazolamide in Persons With Type 1 Diabetes - Dose Finding | Biotech Hunter | Biotech Hunter